Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis

Osteoporosis

Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement

JAMA.

US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Phipps MG, Pignone M, Silverstein M, Simon MA, Tseng CW, Wong JB

doi: 10.1001/jama.2018.7498.

Osteoporosis

2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)

Swiss Med Wkly

Ferrari S, Lippuner K, Lamy O, Meier C

doi: 10.4414/smw.2020.20352

Osteoporosis

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians

Ann Intern Med.

Qaseem A, Forciea MA, McLean RM, Denberg TD; Clinical Guidelines Committee of the American College of Physicians

doi: 10.7326/M15-1361.

Osteoporosis

Trabecular bone microarchitecture predicts fragility fractures in postmenopausal women on denosumab treatment

Bone.

Butscheidt S, Rolvien T, Vettorazzi E, Frieling I

doi: 10.1016/j.bone.2018.06.022.

T Cells

A Low Frequency of IL-17-Producing CD8⁺ T-Cells Is Associated With Persistent Immune Activation in People Living With HIV Despite HAART-Induced Viral Suppression

Front Immunol.

Perdomo-Celis F, Feria MG, Taborda NA, Rugeles MT

doi: 10.3389/fimmu.2018.02502.

Osteoporosis

Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment

Bone.

Tsourdi E, Makras P, Rachner TD, Polyzos S, Rauner M, Mandanas S, Hofbauer LC, Anastasilakis AD

doi: 10.1016/j.bone.

COMMENTED

Osteoporosis

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density

Osteoporos Int.

Naylor KE, Bradburn M, Paggiosi MA, Gossiel F, Peel NFA, McCloskey EV, Walsh JS, Eastell R

doi: 10.1007/s00198-018-4460-6.

Osteoporosis

Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project

Swiss Med Wkly.

Morell S, Hemmeler C, Amsler F, Gross T

doi: 10.4414/smw.2017.14451

Osteoporosis

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Osteoporos Int.

Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF)

doi: 10.1007/s00198-

Related content

Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement

2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians

Trabecular bone microarchitecture predicts fragility fractures in postmenopausal women on denosumab treatment

A Low Frequency of IL-17-Producing CD8+ T-Cells Is Associated With Persistent Immune Activation in People Living With HIV Despite HAART-Induced Viral Suppression

Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density

Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

A Low Frequency of IL-17-Producing CD8⁺ T-Cells Is Associated With Persistent Immune Activation in People Living With HIV Despite HAART-Induced Viral Suppression